Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Desai, Abhilash K.
Schwartz, Lori
and
Grossberg, George T.
2012.
Behavioral Disturbance in Dementia.
Current Psychiatry Reports,
Vol. 14,
Issue. 4,
p.
298.
Schwarz, Stefan
Froelich, Lutz
and
Burns, Alistair
2012.
Pharmacological treatment of dementia.
Current Opinion in Psychiatry,
Vol. 25,
Issue. 6,
p.
542.
Seitz, Dallas P.
Gill, Sudeep S.
Herrmann, Nathan
Brisbin, Sarah
Rapoport, Mark J.
Rines, Jenna
Wilson, Kimberley
Le Clair, Ken
and
Conn, David K.
2013.
Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.
International Psychogeriatrics,
Vol. 25,
Issue. 2,
p.
185.
Porsteinsson, Anton P
Smith, Jessica S
Keltz, Melanie A
and
Antonsdottir, Inga M
2014.
Can antidepressant medication relieve agitation in Alzheimer’s disease?.
Expert Review of Neurotherapeutics,
Vol. 14,
Issue. 9,
p.
969.
Porsteinsson, Anton P
Keltz, Melanie A
and
Smith, Jessica S
2014.
Role of Citalopram in the Treatment of Agitation in Alzheimer’s Disease.
Neurodegenerative Disease Management,
Vol. 4,
Issue. 5,
p.
345.
Murayama-Sung, Lori
and
Ahmed, Iqbal
2015.
Handbook of Consultation-Liaison Psychiatry.
p.
521.
Colijn, Mark A.
Nitta, Bradley H.
and
Grossberg, George T.
2015.
Psychosis in Later Life.
Harvard Review of Psychiatry,
Vol. 23,
Issue. 5,
p.
354.
McClam, Tamela D.
Marano, Christopher M.
Rosenberg, Paul B.
and
Lyketsos, Constantine G.
2015.
Interventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer’s Disease.
Harvard Review of Psychiatry,
Vol. 23,
Issue. 5,
p.
377.
Magierski, Radoslaw
and
Sobow, Tomasz
2016.
Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia.
Expert Review of Neurotherapeutics,
Vol. 16,
Issue. 4,
p.
375.
Wilkins, James M.
and
Forester, Brent P.
2016.
Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.
Current Psychiatry Reports,
Vol. 18,
Issue. 2,
Žmuc Veranič, Lea
Pregelj, Peter
and
Jerin, Aleš
2016.
Treating agitation and aggression in patients with Alzheimer's disease with escitalopram.
Psychogeriatrics,
Vol. 16,
Issue. 6,
p.
384.
Greenblatt, H. Karl
and
Greenblatt, David J.
2016.
Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.
The Journal of Clinical Pharmacology,
Vol. 56,
Issue. 9,
p.
1048.
An, Hoyoung
Choi, Booyeol
Park, Kun-woo
Kim, Do-Hoon
Yang, Dong-Won
Hong, Chang Hyung
Kim, Seong Yoon
and
Han, Seol-Heui
2016.
The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer’s Disease Subjects.
Journal of Alzheimer's Disease,
Vol. 55,
Issue. 2,
p.
727.
Chau, Sarah A.
Liu, Celina S.
Ruthirakuhan, Myuri
Lanctôt, Krista L.
and
Herrmann, Nathan
2016.
Mental Health and Illness of the Elderly.
p.
1.
Bergman, Joseph
Lerner, Paul P.
Sokolik, Shmuel
Lerner, Vladimir
Kreinin, Anatoly
and
Miodownik, Chanoch
2017.
Successful Use of Escitalopram for the Treatment of Visual Hallucinations in Patients With Parkinson Disease.
Clinical Neuropharmacology,
Vol. 40,
Issue. 6,
p.
246.
Rabins, Peter V.
Rovner, Barry W.
Rummans, Teresa
Schneider, Lon S.
and
Tariot, Pierre N.
2017.
Guideline Watch (October 2014): Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias.
Focus,
Vol. 15,
Issue. 1,
p.
110.
Chau, Sarah A.
Liu, Celina S.
Ruthirakuhan, Myuri
Lanctôt, Krista L.
and
Herrmann, Nathan
2017.
Mental Health and Illness of the Elderly.
p.
455.
Farlow, Martin R.
and
Shamliyan, Tatyana A.
2017.
Benefits and harms of atypical antipsychotics for agitation in adults with dementia.
European Neuropsychopharmacology,
Vol. 27,
Issue. 3,
p.
217.
McCue, Robert E.
and
Kelleher, Mary
2017.
Cognitive Behavioral Psychopharmacology.
p.
285.
Chima, Victoria
Ndukwe, Nwayieze
Maldonado, Camille Mendez
Sharma, Priya
and
Lantz, Melinda S.
2018.
Treatment of Late-Life Psychosis.
Current Treatment Options in Psychiatry,
Vol. 5,
Issue. 2,
p.
211.